Grifols Egypt for Plasma Derivatives (GEPD) is a pioneering public‑private joint venture between the Egyptian Government’s National Service Projects Organization and the global plasma‑medicine leader Grifols. The company operates 20 plasma donation centers across Egypt and a state‑of‑the‑art manufacturing complex that can process up to 1 million liters of plasma annually, with the capacity to double in the future. GEPD is the first Egyptian source member of the Plasma Protein Therapeutics Association and the region’s first dedicated plasma‑derivatives venture, positioning it as a key driver of self‑sufficiency and innovation in critical therapies. Its integrated donation, fractionation, purification, and fill‑and‑finish operations, coupled with a comprehensive testing laboratory, enable the rapid development and supply of high‑quality plasma‑derived medicines to the Egyptian healthcare system.
Senior refrigeration engineer will use his advanced engineering knowledge for repairing and maintaining of refrigeration equipment.
Grifols Egypt for Plasma Derivatives (GEPD) is a pioneering public‑private joint venture between the Egyptian Government’s National Service Projects Organization and the global plasma‑medicine leader Grifols. The company operates 20 plasma donation centers across Egypt and a state‑of‑the‑art manufacturing complex that can process up to 1 million liters of plasma annually, with the capacity to double in the future. GEPD is the first Egyptian source member of the Plasma Protein Therapeutics Association and the region’s first dedicated plasma‑derivatives venture, positioning it as a key driver of self‑sufficiency and innovation in critical therapies. Its integrated donation, fractionation, purification, and fill‑and‑finish operations, coupled with a comprehensive testing laboratory, enable the rapid development and supply of high‑quality plasma‑derived medicines to the Egyptian healthcare system.
Grifols Egypt for Plasma Derivatives